InDevR Revenue and Competitors

Boulder, CO USA

Location

$10M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • InDevR's estimated annual revenue is currently $3.7M per year.(i)
  • InDevR's estimated revenue per employee is $77,500
  • InDevR's total funding is $10M.

Employee Data

  • InDevR has 48 Employees.(i)
  • InDevR grew their employee count by 4% last year.

InDevR's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Chief Research and Development OfficerReveal Email/Phone
3
Director Quality AssuranceReveal Email/Phone
4
Chief Operations OfficerReveal Email/Phone
5
Chief Commercial OfficerReveal Email/Phone
6
Senior Scientist and Project ManagerReveal Email/Phone
7
Testing Service ManagerReveal Email/Phone
8
Marketing Communications ManagerReveal Email/Phone
9
Office ManagerReveal Email/Phone
10
Sales Specialist, East CoastReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M110%N/AN/A
#2
$2.8M1813%N/AN/A
#3
$70.2M453-1%N/AN/A
#4
$1.6M10-66%N/AN/A
#5
$3.7M24-8%N/AN/A
#6
$2.9M3728%N/AN/A
#7
$3.1M2025%N/AN/A
#8
$2.5M16-20%N/AN/A
#9
$9.1M590%N/AN/A
#10
$4.2M27-7%N/AN/A
Add Company

What Is InDevR?

InDevR is a global leader in progressive new analytical technologies that enable accelerated development and manufacturing of vaccines and other biotherapeutics. Key products include our VaxArray portfolio of our game-changing multiplexed potency assays for vaccines and the Cypher One system for digital imaging and automated interpretation of hemagglutination assays.

keywords:N/A

$10M

Total Funding

48

Number of Employees

$3.7M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

InDevR News

2022-04-13 - Microarray Market to Witness Huge Growth by 2028 | Takara ...

... Arrayit, Takara Bio, BioGenex, LC Sciences, US Biomax, AXO Science, BioCat, Cepheid, GE Healthcare, InDevR & Qiagen etc.

2019-09-10 - InDevR Raises $7M in Series A Financing

InDevR, Inc., a Boulder, CO-based biotechnology company focused on developing and commercializing novel analytical technologies for biologic process development and monitoring, raised $7m in Series A round of equity financing. Adjuvant Capital made the investment. The company intends to use th ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.7M48-9%N/A
#2
$7.4M489%N/A
#3
$6.1M48100%N/A
#4
$5.4M48-26%N/A
#5
$3.7M48-26%$29M